newsfilter
← Earnings
Earnings Releases·

Albemarle — Third Quarter 2026 Earnings Summary

  • Financial Performance:

    • Net sales reached $1.6 billion for the quarter, a 19% year-over-year increase driven by higher pricing in Energy Storage (+68%) and higher pricing (+10%) and volumes (+3%) in Specialties.
    • Net income attributable to Albemarle was $297 million ($2.15 per diluted share), compared to a net loss of $160.7 million ($1.72 per diluted share) in the prior-year quarter.
    • Adjusted net income was $354 million ($2.58 per diluted share), excluding restructuring and other related charges.
    • Adjusted EBITDA totaled $646 million, an 186% year-over-year increase, primarily due to higher pricing in Energy Storage, increased pricing and volumes in Specialties, and cost and productivity improvements.
    • Cash from operating activities was $406 million, with free cash flow of $325 million.
    • Operating cash flow conversion was 63%, supported by a cash dividend from the Talison joint venture which offset timing of working capital changes.
    • Year-to-date operating cash flow for the first nine months was $1.5 billion, a $568 million increase compared to the prior-year period, with year-to-date operating cash flow conversion at 67%.
    • Year-to-date free cash flow was $1.2 billion.
    • Total debt was $1.9 billion as of September 30, 2026, resulting in a net debt to adjusted EBITDA ratio of approximately 0.3.
    • Estimated liquidity was $3.4 billion, comprising $1.8 billion in cash and cash equivalents, $1.5 billion available under the revolver, and $79 million available under other credit lines.
  • Guidance and Future Outlook:

    • Full-year 2026 Specialties adjusted EBITDA outlook was raised to $350-$375 million (previously $275-$325 million), driven by cost and productivity improvements.
    • Full-year 2026 capital expenditure forecast was reduced to $300-$350 million (previously approximately $500 million), reflecting capital efficiency improvements and resequencing of early-stage projects.
    • Total corporate net sales for 2026 are projected between $4.1-$4.3 billion (at FY 2025 avg. lithium prices), $5.7-$6.0 billion (at Q1 2026 avg. prices), or $7.5-$7.8 billion (at 2021-2025 avg. prices).
    • Total corporate adjusted EBITDA for 2026 is projected between $0.9-$1.0 billion (at FY 2025 avg. prices), $2.4-$2.6 billion (at Q1 2026 avg. prices), or $4.2-$4.4 billion (at 2021-2025 avg. prices).
    • Energy Storage production volumes are expected to increase year-over-year in 2026.
    • Sales volumes for 2026 are expected to be in the range of 225 to 235 kilotons lithium carbonate equivalent (LCE).
    • Fourth quarter 2026 net sales and adjusted EBITDA are expected to decrease sequentially due to lower market pricing and the consumption of higher-cost spodumene inventory.
    • Specialties net sales for 2026 are expected to be $1.4-$1.6 billion.
    • Other corporate adjusted EBITDA (including FX, Ketjen equity income, and PCS) is expected to be ($20)-$20 million.
    • Depreciation and amortization for 2026 is expected to be $660-$680 million.
    • Interest and financing expenses for 2026 are expected to be $120-$140 million.
  • Business Segments and Product Lines:

    • Energy Storage: Net sales were $1.1 billion (up 58% year-over-year), driven by higher pricing. Adjusted EBITDA was $560 million (up 351%). Sales volume was 56 kT LCE, down 18.8% year-over-year due to timing events in the prior year including inventory destocking and higher-than-usual spodumene shipments. Average realized price was $20.02/kg LCE, up 94.7% year-over-year.
    • Specialties: Net sales were $389 million (up 13% year-over-year), driven by higher pricing (+10%) and volumes (+3%). Adjusted EBITDA was $99 million (up 31%), driven by favorable pricing in bromine and derivatives, productivity improvements, and proactive management of cost escalations. The Jordan Bromine Company (JBC) joint venture achieved record quarterly production.
    • Talison's Chemical Grade Plant 3 (CGP3) achieved 30 days of nameplate performance in September.
    • The company delivered more than $150 million in year-to-date run-rate cost and productivity improvements, achieving the high end of its full-year target.
  • Market and Competitive Landscape:

    • Global lithium demand was up 48% year-to-date through August, driven by electric vehicles and energy storage.
    • Outlook scenarios assume flat market pricing flowing through Energy Storage's current contract book, which includes approximately 40% of salts volume (or one-third of total volumes) on long-term agreements.
    • Spodumene pricing is assumed to average 10% of the lithium carbonate equivalent (LCE) price in outlook scenarios.
    • Specialties outlook reflects modest volume growth in key end markets led by semiconductors, oil and gas, flame retardants, and pharmaceuticals, with steady demand in automotive and petrochemical markets.
  • Risks and Challenges:

    • A fire on June 9 caused a delay in the Talison CGP3 ramp.
    • Supply chain related cost escalations due to the conflict in the Middle East impacted Specialties, though cost and productivity improvements offset these impacts.
    • Fourth-quarter margins are expected to decrease sequentially due to the consumption of higher-cost spodumene inventory purchased in prior periods.
    • The refining catalyst business earnings are now classified as equity income following the sale of a controlling stake in Ketjen's refining catalyst solutions business on March 2, 2026.
  • Management Commentary and Tone:

    • Kent Masters, Chairman and CEO, stated the company delivered a "solid quarter" reflecting "disciplined execution across the enterprise."
    • Management expressed confidence in the long-term outlook for the industry due to the 48% year-to-date increase in global lithium demand.
    • The company will continue to prioritize high-return organic growth by leveraging its advantaged resource base, capital spending efficiency, and financial flexibility.
  • Other Key Points:

    • The company sold a 51% stake in Ketjen's refining catalyst solutions business on March 2, 2026; earnings from this business are now classified as equity income.
    • The company recorded a net loss of $52.7 million related to the divestiture of its Refining Solutions business and Eurecat joint venture in the first quarter of 2026.
    • The company completed a $1.3 billion debt tender and redemption in the first quarter of 2026, resulting in a gain on early extinguishment of debt of $12.5 million.
    • Restructuring charges and asset write-offs for the quarter were $8.0 million, including charges related to placing Kemerton Train 1 into care and maintenance.
    • Year-to-date capital expenditures were $251 million, a decrease of $184 million versus the prior-year period.
    • The adjusted effective tax rate for the quarter was 16.4% as reported, or 5.8% on an adjusted basis.
Company
ALBEMARLE CORP
Sector
Basic Materials
Industry
Specialty Chemicals